Low copy number DNA template can render polymerase chain reaction error prone in a sequence-dependent manner.
about
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for MolecularTargeted deep sequencing reveals no definitive evidence for somatic mosaicism in atrial fibrillation.Mutation detection by real-time PCR: a simple, robust and highly selective method.Intratumoral distribution of EGFR mutations and copy number in metastatic lung cancer, what impact on the initial molecular diagnosis?Discovery of rare mutations in populations: TILLING by sequencing.The role of replicates for error mitigation in next-generation sequencing.KRAS genotyping in rectal adenocarcinoma specimens with low tumor cellularity after neoadjuvant treatment.Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for MolecularData-driven unbiased curation of the TP53 tumor suppressor gene mutation database and validation by ultradeep sequencing of human tumors.A comparison of EGFR mutation testing methods in lung carcinoma: direct sequencing, real-time PCR and immunohistochemistryRapid, sequence-specific detection of unpurified PCR amplicons via a reusable, electrochemical sensor.Detection and characterization of classical and "uncommon" exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing.Next-generation sequencing of lung cancer EGFR exons 18-21 allows effective molecular diagnosis of small routine samples (cytology and biopsy).Comparison of pre-analytical FFPE sample preparation methods and their impact on massively parallel sequencing in routine diagnosticsMassively parallel sequencing fails to detect minor resistant subclones in tissue samples prior to tyrosine kinase inhibitor therapy.The Core/E1 domain of hepatitis C virus genotype 4a in Egypt does not contain viral mutations or strains specific for hepatocellular carcinoma.Comparison of the fecal microbiota of dholes high-throughput Illumina sequencing of the V3-V4 region of the 16S rRNA gene.Postmortem genetic testing for conventional autopsy-negative sudden unexplained death: an evaluation of different DNA extraction protocols and the feasibility of mutational analysis from archival paraffin-embedded heart tissueDramatic reduction of sequence artefacts from DNA isolated from formalin-fixed cancer biopsies by treatment with uracil- DNA glycosylase.Genetic Testing and Tissue Banking for Personalized Oncology: Analytical and Institutional Factors.TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.Evaluation of epidermal growth factor receptor mutations based on mutation specific immunohistochemistry in non-small cell lung cancer: A preliminary study.Investigation of somatic NKX2-5 mutations in congenital heart diseaseA rapid and reliable test for BRCA1 and BRCA2 founder mutation analysis in paraffin tissue using pyrosequencingPreanalytic parameters in epidermal growth factor receptor mutation testing for non-small cell lung carcinoma: A review of cytologic seriesLimited copy number-high resolution melting (LCN-HRM) enables the detection and identification by sequencing of low level mutations in cancer biopsiesSeize the opportunity: underutilization of fine-needle aspiration biopsy to inform targeted cancer therapy decisions.The role of cytology specimens in molecular testing of solid tumors: techniques, limitations, and opportunities.Functional DNA quantification guides accurate next-generation sequencing mutation detection in formalin-fixed, paraffin-embedded tumor biopsiesPCR-based gene synthesis to produce recombinant proteins for crystallization.Pre-Analytical Considerations for Successful Next-Generation Sequencing (NGS): Challenges and Opportunities for Formalin-Fixed and Paraffin-Embedded Tumor Tissue (FFPE) Samples.Molecular genetic and epigenetic analysis of NCX2/SLC8A2 at 19q13.3 in human gliomas.Metastatic colorectal cancer KRAS genotyping in routine practice: results and pitfalls.Molecular profiling of the "plexinome" in melanoma and pancreatic cancer.EGFR with TKI-sensitive mutations in exon 19 is highly expressed and frequently detected in Chinese patients with lung squamous carcinoma.Epidermal growth factor receptor in lung cancer: the amazing interplay of molecular testing and cytopathology.Validation of the short amplicon multiplex q8 including the German DNA database systems.No somatic genetic change in the paxillin gene in nonsmall-cell lung cancer.ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation.VHL mutations and dysregulation of pVHL- and PTEN-controlled pathways in multilocular cystic renal cell carcinoma.
P2860
Q26828860-F4264E90-7EC4-45D1-986D-B5EFAEF61434Q30392171-A7C5098A-C176-4767-AC65-00767F1DD786Q33412122-A8BA8B68-E215-49DF-BC55-BA0FFD3D6151Q33700689-EBA3E981-1585-4CFF-8307-04FF860705EFQ33885544-1C1845E6-D4E3-4E87-BB42-3C36F9DBDD1EQ33921022-55C9C0B9-9DB3-4B69-9A8D-A91EDAF3186DQ34142761-8F9A16BF-7E57-4CFF-AFD8-38335F7C6FBDQ34159011-FE1871EB-2EB8-42CF-8CF5-8E2EB6CA856DQ34281386-44902327-0C60-43EE-B532-7250658B6504Q34405695-105334F7-E9BF-48BC-9A6E-A8F33EE3D9EEQ34572881-FFFF1A7C-0232-4BE3-B16A-9067C5140256Q34622721-E539FF4E-1E1E-49FA-BD40-EA208C781CDDQ35078128-53FEAF72-FF6C-4AAF-A2AB-8BFD83EE9460Q35221918-8133AD75-7FFC-458A-B250-E6B3637B82E0Q35497448-D71DBED6-BBA5-434A-8358-0B00D0397023Q35552537-A4BBBC77-F779-45AC-8984-D99EDE0852C3Q35884348-ECD7C9E8-497D-48A7-9708-D80DC846DDE8Q35904766-3F692EA7-E11B-4FB1-A1B4-E7B8BA368CEEQ36071877-9D050DED-3826-483E-87D8-0CC29073B342Q36441399-02DA22B8-C1A8-4595-B764-881554D98169Q36825602-5BFCEAF7-50EC-425C-995E-646FF907A940Q36966128-762B5B69-71EE-4A2F-9620-B22C2C13C735Q37066669-F73A11AC-2D2B-43CC-AA5A-A59ACB8E2CA0Q37164443-D6AC0D1F-8661-465A-931A-4C67F1DAB699Q37296060-74966EF2-53DA-4CF7-9329-F8B69D28F597Q37397595-2062613D-AF3D-4DE6-A835-BD1873311C62Q37587884-7CDBEF37-F98E-40DF-B952-C6CE02784A21Q38012417-4DB127DC-AB90-43BB-9845-AE2D2F632EC8Q38649740-76528301-451B-4615-BB03-175C52027ECFQ38782055-751CA7D3-845C-4BB5-8A12-7C11D7FDBB01Q38818732-1745FBE2-FE85-4C58-8035-19D1FB8E8AF3Q39743687-1A726C2D-4226-47B4-BB19-2333FC1A15F6Q39757608-8226BDB5-548B-49EB-862A-6BCB7A37CC76Q41692560-3464F06C-B412-47DB-80CF-A3D1515559D9Q42731684-A3F005FE-0E98-4455-9D9B-31E98663B593Q44986184-6375BA0F-792D-404F-8E58-26C368565610Q47731578-B24E85F7-9FA3-4905-9243-9A28E8257B94Q48034099-21C9E29C-98CE-49B0-92EE-D6CE91C91A9DQ50146313-DFBA5ADC-201C-4863-8343-CC0132319686Q54627123-65F09325-AA93-4ED7-BABB-EEFED16E08E2
P2860
Low copy number DNA template can render polymerase chain reaction error prone in a sequence-dependent manner.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Low copy number DNA template c ...... n a sequence-dependent manner.
@en
type
label
Low copy number DNA template c ...... n a sequence-dependent manner.
@en
prefLabel
Low copy number DNA template c ...... n a sequence-dependent manner.
@en
P2860
P50
P1476
Low copy number DNA template c ...... n a sequence-dependent manner.
@en
P2093
Marianne Doré Hansen
P2860
P356
10.1016/S1525-1578(10)60006-2
P577
2005-02-01T00:00:00Z